State Ledger
Company profile

ACTUATE THERAPEUTICS, INC. CIK 1652935

Ticker
ACTU (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Fort Worth, TX 76107
Fiscal year end
2025 (FY)
Market Data
Close
$0.46
Change
-$0.17
Change %
-26.71%
Volume
14,815

ACTU · trading date Oct 13, 2026 · previous close $0.62 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$22.23M
Total assets
$14.04M
Total liabilities
$6.11M
Stockholders' equity
$7.92M
Cash & equivalents
$13.16M
Operating income
-$22.50M
Operating cash flow
-$19.21M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
43.5%
Equity / assets
56.5%
CapEx / revenue
—
Operating cash flow / net income
0.86×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$22.23M $14.04M $6.11M $7.92M
2024 — -$27.29M $9.32M $9.21M $104.2K
2023 — -$24.74M $3.00M $8.44M -$99.63M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-08-14
Financials filed via
Form 10-K
filed 2026-03-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Fort Worth, TX 76107
1751 RIVER RUN
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:57 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Texas — Public Companies